Our results indicate that the sensitivity of HNSCC cell lines to c-MET targeting agents is independent of their c-MET addiction and is more likely to be influenced by other compensatory intracellular kinase signaling pathways such as AKT or ERK1/2. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.